Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Immunotech Biopharm Ltd ( (HK:6978) ) has provided an update.
Immunotech Biopharm Ltd has announced the postponement of its board meeting initially scheduled for March 28, 2025, to March 31, 2025. This delay is due to the need for additional time to finalize the company’s annual results for the year ending December 31, 2024, which could impact the company’s reporting schedule and stakeholder expectations.
More about Immunotech Biopharm Ltd
Immunotech Biopharm Ltd is a company incorporated in the Cayman Islands, operating in the biopharmaceutical industry. It focuses on the development and commercialization of innovative therapies, likely targeting various medical conditions.
YTD Price Performance: 83.48%
Average Trading Volume: 708,350
Technical Sentiment Signal: Sell
Current Market Cap: HK$2.17B
See more data about 6978 stock on TipRanks’ Stock Analysis page.
Trending Articles:
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue